Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9103556 | Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) | 2005 | 7 Pages |
Abstract
15 deoxy-Î12,14-prostaglandin2 (15d-PGJ2) is known to inhibit the proliferation of hepatic stellate cells (HSCs), major cellular components that cause hepatic fibrosis, in vitro. It also induces oxidative stress, which results in hepatic myofibroblast death. On the other hand, oxidative stress generally induces HSC proliferation and collagen synthesis in vitro, and liver fibrogenesis in vivo. In this study, we evaluated the effects of 15d-PGJ2 at various concentrations on the viability and collagen synthesis of HSCs. 15d-PGJ2 increased intracellular reactive oxygen species (ROS), and reduced the viability of human HSCs at concentrations ⩾5 μM by inducing apoptotic cell death. In addition, the antioxidants α-tocopherol and N-acetylcysteine (NAC) blocked 15d-PGJ2-induced HSC death. Collagen I synthesis was increased 1.5-fold by 0.5 μM 15d-PGJ2 treatment, but was reduced to 30% of the control level by 10 μM 15d-PGJ2, and NAC pretreatment prevented these changes in collagen production by 15d-PGJ2. We conclude that 15d-PGJ2 may either induce or prevent hepatic fibrogenesis depending on its concentration.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Kyung-Ah Kim, Young-Suk Lim, Kang-Mo Kim, Jung-Hwan Yoon, Hyo-Suk Lee,